March 13, 2014  BY Sarah Redohl

Animal Health Specialties, a local biotech startup based in the MU Life Sciences Incubator, received a $230,000 investment from Columbia-based angel investor group Centennial Investors Wednesday, March 12.

“We are pretty excited about the investment,” said Centennial Investor member Greg Wolff. “Animal Health Specialties is working on what could be blockbuster drugs that will change everything for pet owners, farmers and others who need production animals.”

The “blockbuster drugs” Wolff mentions include one to treat cachexia, wasting of lean body mass often associated with cancer, in companion animals. The company is also developing a drug to help eliminate the need for antibiotics for production animals. According to the Food and Drug Administration, around 80 percent of the 7 million pounds of antibiotics sold in the United States are consumed by livestock and poultry.

“Treating cachexia and helping to eliminate the need for antibiotics for these animals will change domesticated animal health as we know it,” Wolff said.

Kenneth Gruber, president and CEO of Tensive Controls, Inc.—of which Animal Health Specialties is a subsidiary—said it was the resources of the University of Missouri and Centennial Investors’ assistance that have made the company’s progress possible.

“Dr. Gruber’s work and the effort to commercialize it represent a wonderful alliance with the University of Missouri,” said Carolyn Henry, who works with Gruber at the University of Missouri Department of Veterinary Medicine and Surgery. “I really do believe we will do great things together.”

According to a press release, “Centennial Investors reviews a wide range of deals each year, and members invest in a select few that they think will be great successes.”

“The substantial interest among Centennial Investors members was based on respect for Dr. Gruber’s credentials as a scientist as well as the opportunity for Animal Health Specialties to commercialize discoveries to improve animal health,” said Bruce Walker, chair of Centennial Investors.

Jake Halliday is the president and CEO of the Missouri Innovation Center, which runs the MU Life Sciences Incubator. In his role at the Incubator, he has assisted with the launch and growth of Animal Health Specialties.

“What I like most about Animal Health Specialties is the company’s platform technology that will generate a steady pipeline of animal health products and, from an investor standpoint, create more shots on goal.”

Advertise With Us

Recent News

Did you miss Top of the Town in July? We celebrated your favorite B2B services! #CoMO

Twitter Media

Want to know what it's like to dive with sharks without actually having to dive with sharks? #CoMo

Wondering what 20Under40 alumni are up to? Read about class of 2001's Lili Vianello, founder of @VisionworksMC #como

We interviewed the 20 Under 40 class. Each were interviewed in this chair. Who's in the class? Stay tuned. #CoMO

Twitter Media

Congratulations to @CommerceBank, celebrating 150 years in business. #CoMO

You aren't getting CBT's newsletter? Sign up for events, behind the scenes photos and more!

Loftin will transition away from MU Chancellor.…

There's great local coverage of this situation. Thanks, to #CoMO media outlets for keeping our community informed.…

UM System President Tim Wolfe has announced his resignation. #CoMO

To improve your company's marketing skills, build a ham sandwich. From @MayeCreate's Monica Pitts: #CoMO #marketing

Happy 10th Bday to our partners at @MayeCreate! Thank you for inviting us, Monica! #CoMO

Twitter Media

It's CBT #StartupSpotlight Time! Ye Olde Lady & Pint brings an authentic pub attitude to CoMo's bar scene. Check it:

The Shelter Insurance fountain has been a staple of #como life. So has it changed much?

The CBT newsletter is out. Read it for some behind the scenes photos and good old-fashioned fun! #como

Get to know Skip Grossnickle, The Insurance Group, in 10 Questions: #como #insurance